1. $HPTX $HZNP: HYPERION THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Hyperion T... http://stockwires.com/hyperion-therapeutics-investor-alert-faruqi-amp-faruqi-llp-announces-the-investigation-of-hyperion-therapeutics-inc-over-the-proposed-sale-of-the-company-to-horizon-pharma-plc-hptx

  2. $HPTX Revenue is Rising. Here s the Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=HPTX&financial_bar=Revenue+(TTM+US$+Millions)&financial_line=Revenue+(TTM+US$+Millions)&start_date=03/31/2013&end_date=12/31/2014&show_line=false&sk=ad3e472cf4ccc4a344b4c0c2cb2f2457

  3. $MACK vs. $GHDX vs. $HPTX vs. $HALO Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=MACK|GHDX|HPTX|HALO|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  4. Top 5 highest RSI s in the health care sector: $VOLC $SLXP $HPTX $PRGO $CNXR... Most overbought stocks in the sector

  5. Tender offer statement by Third Party http://www.conferencecalltranscripts.org/no/summary/?id=1610695 $HPTX

  6. $HPTX: New SEC Filing for HPTX: Form SC TO-T/A, No. 0001193125-15-128241 http://stocknewsflow.com/1386858_000119312515128241_0001193125-15-128241

  7. #IBD Estimate Beaters $TA $ISIS $ABMD $RDN $CYBR $DATA $HPTX $XON $HW $ZLTQ

  8. $HPTX: SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Hyperion Ther... http://stockwires.com/shareholder-alert-brodsky-amp-smith-llc-announces-investigation-of-the-board-of-directors-of-hyperion-therapeutics-inc

  9. Scan results - 1,2,3 Pullback Bullish today: $ON $MSG $WCN $TREX $CTB $HPTX $MSCI $LII $WBS $EPE ... http://swingtradebot.com/events/35/equities?selected_date=2015-04-10

  10. $HPTX Revenue is Expanding. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=HPTX&financial_bar=Revenue+(TTM+US$+Millions)&financial_line=Revenue+(TTM+US$+Millions)&start_date=03/31/2013&end_date=12/31/2014&show_line=false&sk=ad3e472cf4ccc4a344b4c0c2cb2f2457

  11. $HPTX, 13G filed by Fmr LLC http://www.filingsanalysis.com/sec/44915N101/2014/09/30/, http://www.filingsanalysis.com/managers.php?id=0000315066

  12. Statement of acquisition of beneficial ownership by individuals http://www.conferencecalltranscripts.org/no/summary2/?id=1605558 $HPTX

  13. $HZNP is hold after the deal with $HPTX. Check this out here: http://seekingalpha.com/article/3057506-horizon-pharma-and-hyperion-therapeutics-still-upside-or-not

  14. $NLNK vs. $HPTX vs. $HALO vs. $MACK Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=NLNK|HPTX|HALO|MACK|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  15. $HPTX is the #1 holding in this new ETF: BioShares Biotechnology Products Fund - BBP

  16. $AMRN vs. $HPTX vs. $SPPI vs. $ENTA Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=AMRN|HPTX|SPPI|ENTA|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  17. $MNTA vs. $AEGR vs. $HPTX vs. $ENTA Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=MNTA|AEGR|HPTX|ENTA|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  18. $GALE vs. $ENTA vs. $HPTX vs. $MDXG Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=GALE|ENTA|HPTX|MDXG|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  19. $AMRN vs. $ENTA vs. $INFI vs. $HPTX Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=AMRN|ENTA|INFI|HPTX|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  20. $MNTA vs. $INFI vs. $ENTA vs. $HPTX Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=MNTA|INFI|ENTA|HPTX|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  21. $AMRN vs. $INFI vs. $HPTX vs. $SPPI Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=AMRN|INFI|HPTX|SPPI|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  22. $HPTX, 13D filed by New Enterprise Associates 12, Limited Partnership http://www.filingsanalysis.com/sec/44915N101/2014/09/30/, http://www.filingsanalysis.com/managers.php?id=0001383391

  23. $HPTX: New SEC Filing for HPTX: Form SC 13D/A, No. 0001072613-15-000249 http://stocknewsflow.com/1386858_000107261315000249_0001072613-15-000249

  24. New Enterprise Associates just provided an update on activist position in Hyperion Therapeutics http://www.conferencecalltranscripts.org/13D/summary2/?id=1599690 $HPTX

  25. $GALE vs. $HPTX vs. $SPPI vs. $ENTA Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=GALE|HPTX|SPPI|ENTA|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)